These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15791692)

  • 1. Hematosalpinx: an unusual complication after medical abortion with oral mifepristone and misoprostol.
    Lin SK; Ho ES; Chen YJ
    Ultrasound Obstet Gynecol; 2005 Apr; 25(4):416-7. PubMed ID: 15791692
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormal expression of MMP-9 and imbalance of MMP-9/TIMP-1 is associated with prolonged uterine bleeding after a medical abortion with mifepristone and misoprostol.
    Li L; Zhou Z; Huang L
    Acta Obstet Gynecol Scand; 2009; 88(6):673-9. PubMed ID: 19353331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deaths from Clostridium sordellii after medical abortion.
    Sicard D
    N Engl J Med; 2006 Apr; 354(15):1645-7; author reply 1645-7. PubMed ID: 16615188
    [No Abstract]   [Full Text] [Related]  

  • 4. Clostridium sordellii toxic shock syndrome after medical abortion with mifepristone and intravaginal misoprostol--United States and Canada, 2001-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Jul; 54(29):724. PubMed ID: 16049422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mifepristone and misoprostol for the treatment of early pregnancy failure: a pilot clinical trial.
    Schreiber CA; Creinin MD; Reeves MF; Harwood BJ
    Contraception; 2006 Dec; 74(6):458-62. PubMed ID: 17157102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Home use of two doses of misoprostol after mifepristone for medical abortion: a pilot study in Sweden and France.
    Clark WH; Hassoun D; Gemzell-Danielsson K; Fiala C; Winikoff B
    Eur J Contracept Reprod Health Care; 2005 Sep; 10(3):184-91. PubMed ID: 16318966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical vs. surgical management of early pregnancy failure.
    Shukunami K; Nishijima K; Kotsuji F
    N Engl J Med; 2005 Dec; 353(22):2403-4; author reply 2403-4. PubMed ID: 16319392
    [No Abstract]   [Full Text] [Related]  

  • 8. Deaths from Clostridium sordellii after medical abortion.
    Baulieu EE
    N Engl J Med; 2006 Apr; 354(15):1645-7; author reply 1645-7. PubMed ID: 16611961
    [No Abstract]   [Full Text] [Related]  

  • 9. Clostridium sordellii infection in medical abortion.
    Winikoff B
    Clin Infect Dis; 2006 Dec; 43(11):1447-8. PubMed ID: 17083019
    [No Abstract]   [Full Text] [Related]  

  • 10. Mifepristone and misoprostol sequential regimen side effects, complications and safety.
    Sitruk-Ware R
    Contraception; 2006 Jul; 74(1):48-55. PubMed ID: 16781261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal Clostridium sordellii infections after medical abortions.
    Meites E; Zane S; Gould C;
    N Engl J Med; 2010 Sep; 363(14):1382-3. PubMed ID: 20879895
    [No Abstract]   [Full Text] [Related]  

  • 12. Medical management of early pregnancy failure: efficacy.
    Chen BA; Creinin MD
    Semin Reprod Med; 2008 Sep; 26(5):411-22. PubMed ID: 18825609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol.
    Raghavan S; Comendant R; Digol I; Ungureanu S; Friptu V; Bracken H; Winikoff B
    Contraception; 2009 Feb; 79(2):84-90. PubMed ID: 19135563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal vs. sublingual misoprostol with mifepristone for cervical priming in second-trimester abortion by dilation and evacuation: a randomized clinical trial.
    Carbonell JL; Gallego FG; Llorente MP; Bermudez SB; Sala ES; González LV; Texido CS
    Contraception; 2007 Mar; 75(3):230-7. PubMed ID: 17303495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comment: pathophysiology of mifepristone-induced septic shock due to Clostridium sordellii.
    Sicard D; Chauvelot-Moachon L
    Ann Pharmacother; 2005 Dec; 39(12):2142-3. PubMed ID: 16288074
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial.
    Shannon C; Wiebe E; Jacot F; Guilbert E; Dunn S; Sheldon WR; Winikoff B
    BJOG; 2006 Jun; 113(6):621-8. PubMed ID: 16709204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone.
    Akin A; Dabash R; Dilbaz B; Aktün H; Dursun P; Kiran S; Aksan G; Doğan B; Winikoff B
    Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):169-75. PubMed ID: 19565414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Möbius syndrome in a neonate after mifepristone and misoprostol elective abortion failure.
    Bos-Thompson MA; Hillaire-Buys D; Roux C; Faillie JL; Amram D
    Ann Pharmacother; 2008 Jun; 42(6):888-92. PubMed ID: 18460590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion.
    Chai J; Tang OS; Hong QQ; Chen QF; Cheng LN; Ng E; Ho PC
    Hum Reprod; 2009 Feb; 24(2):320-4. PubMed ID: 19049993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.